Skip to main content
Signal8
Macdonald R. Loch profile photo

R. Loch Macdonald

CIK: 0001653008

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Grace Therapeutics, Inc. logo
GRCE

Grace Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Grace Therapeutics, Inc. logo
    GRCE

    Grace Therapeutics, Inc.

    Aug 28, 2026
    Award(A)

    Stock Option (Right to Buy)

    Direct
    54.7K shares-
  • Grace Therapeutics, Inc. logo
    GRCE

    Grace Therapeutics, Inc.

    Apr 14, 2025
    Award(A)

    Stock Option (Right to Buy)

    Direct
    40K shares-

1-2 of 2

About Macdonald R. Loch

Macdonald R. Loch (SEC CIK 0001653008) files insider reports with the SEC as Chief Medical Officer of Grace Therapeutics, Inc. (GRCE).

Signal8 holds 2 ownership filings by Macdonald R. Loch, all Form 4s, filed between Apr 16, 2025 and Sep 1, 2026. Those filings report 2 transactions, from Apr 14, 2025 to Aug 28, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Macdonald R. Loch's filings is in PRINCETON, NJ.

Recent filings by Macdonald R. Loch

  • Aug 28, 2026: Grant or award of GRCE derivative securities (Form 4, code A).
  • Apr 14, 2025: Grant or award of GRCE derivative securities (Form 4, code A).

Other insiders filing for Grace Therapeutics, Inc. (GRCE)

How to read Form 4 transaction codes